# Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery

> **NCT07274670** · NA · COMPLETED · sponsor: **Udayana University** · enrollment: 58 (actual)

## Conditions studied

- Thyroid Cancer
- Goiter
- Hyperthyroidism

## Interventions

- **DRUG:** Dexmedetomidine & Bupivacaine.
- **DRUG:** Bupivacain

## Key facts

- **NCT ID:** NCT07274670
- **Lead sponsor:** Udayana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-11-10
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07274670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07274670, "Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07274670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*